← All Sponsors
SPONSOR

Impact Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Solid TumorAdvanced Solid Tumor
NCT05269316 Phase 1, Phase 2
Recruiting

Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Solid Tumor
United States, Australia, China View Trial →